List of articles with "Immunotherapy"

Cancer Immunotherapy Growth

Cancer Immunotherapy Growth

United States Boston Cancer Treatment oncology Immunotherapy
Vetigenics Starts K9 Study

Vetigenics Starts K9 Study

United States Immunotherapy Madison Vetigenics K9 Study
RyboDyn Joins Lilly Labs

RyboDyn Joins Lilly Labs

USA San Diego Immunotherapy Lilly RyboDyn
Citius Launches LYMPHIR™

Citius Launches LYMPHIR™

United States Cranford Immunotherapy LYMPHIR Citius Oncology
HCB101 Immunotherapy Data

HCB101 Immunotherapy Data

United States Chicago Immunotherapy HanchorBio HCB101
Lotte Invests in Elixiron

Lotte Invests in Elixiron

Japan Immunotherapy Tokyo Lotte Holdings Elixiron
Scinai Gains Italian Clearance

Scinai Gains Italian Clearance

Italy Jerusalem Immunotherapy Scinai Pincell
Adela's Innovative Blood Test

Adela's Innovative Blood Test

United States Immunotherapy cancer detection Foster City, California ADELA
Resistance Mechanisms in Immunotherapy

Resistance Mechanisms in Immunotherapy

Israel Immunotherapy OncoHost Lung Cancer Binyamina
BioVaxys Consolidation Plan

BioVaxys Consolidation Plan

Canada Vancouver Immunotherapy biotechnology BioVaxys Technology
Diakonos Raises $20 Million

Diakonos Raises $20 Million

United States Houston Immunotherapy Glioblastoma Diakonos Oncology
Scinai Q1 2025 Results

Scinai Q1 2025 Results

Israel Jerusalem Immunotherapy Scinai CDMO
BioVaxys & Horizon Deal

BioVaxys & Horizon Deal

Canada Vancouver Immunotherapy BioVaxys Horizon Corp
Precision Cancer Biotech

Precision Cancer Biotech

Immunotherapy Akoya Biosciences Oncolytics
OncoHost EIC Grant

OncoHost EIC Grant

Israel Immunotherapy Precision Medicine OncoHost Binyamina
NeutroFlow's €2.5M Grant

NeutroFlow's €2.5M Grant

Germany Immunotherapy Heidelberg NeutroFlow Predictive Biomarkers
Hyundai ADM Bio Focus Shift

Hyundai ADM Bio Focus Shift

South Korea Seoul Immunotherapy Penetrium Hyundai ADM Bio
Hope in Cancer Treatments

Hope in Cancer Treatments

Canada Vancouver Cancer Research Immunotherapy Oncolytics Biotech
Immunotherapy Breakthrough

Immunotherapy Breakthrough

United States Los Angeles Immunotherapy Clinical Trial Stand Up To Cancer
Dr. Tine Gaziel Joins HERVolution

Dr. Tine Gaziel Joins HERVolution

Immunotherapy Denmark Copenhagen HERVolution Dr. Tine Gaziel
Diamyd Medical's Innovations

Diamyd Medical's Innovations

None Immunotherapy Type 1 Diabetes Diamyd Medical
NEUVOGEN Expands Advisory Board

NEUVOGEN Expands Advisory Board

USA San Diego Immunotherapy Cancer Vaccine NEUVOGEN
Investors Eye New Cancer Therapies

Investors Eye New Cancer Therapies

None Immunotherapy Oncolytics Biotech Young Adult Cancer
Immunotherapy Advances

Immunotherapy Advances

USA San Diego Immunotherapy Oncolytics Biotech pelareorep
Weill Cancer Hub East

Weill Cancer Hub East

United States New York Cancer Research Immunotherapy Weill Family Foundation
iOncologi Acquires TargImmune

iOncologi Acquires TargImmune

United States Gainesville Immunotherapy iOncologi TargImmune
Luminary's CAR T Therapy

Luminary's CAR T Therapy

United States Minneapolis Immunotherapy Luminary Therapeutics CAR T
Compugen Fireside Chat

Compugen Fireside Chat

United States Immunotherapy Compugen Miami Beach CGEN
FDA Approves Fapon Biopharma Drug

FDA Approves Fapon Biopharma Drug

China Immunotherapy Dongguan Fapon Biopharma FP008
FP008 FDA Approval

FP008 FDA Approval

USA Immunotherapy Dongguan Fapon Biopharma FP008
FP008 Receives FDA Approval

FP008 Receives FDA Approval

USA Immunotherapy Dongguan Fapon Biopharma FP008
Immunotherapy FP008 Approved

Immunotherapy FP008 Approved

China Immunotherapy Dongguan Fapon Biopharma FP008
OncoHost & Gustave Roussy

OncoHost & Gustave Roussy

Israel Immunotherapy OncoHost Binyamina Gustave Roussy
HPV16 HNSCC Market Growth

HPV16 HNSCC Market Growth

None Immunotherapy HPV16 HNSCC
Oncolytics Nasdaq Notification

Oncolytics Nasdaq Notification

United States NASDAQ San Diego Immunotherapy Oncolytics Biotech
AbbVie Xilio Collaboration

AbbVie Xilio Collaboration

United States Immunotherapy AbbVie North Chicago Xilio Therapeutics
BioVaxys Private Placement

BioVaxys Private Placement

Canada Vancouver Immunotherapy Private Placement BioVaxys
ANT308 Breakthrough

ANT308 Breakthrough

USA Atlanta Immunotherapy Cambium Oncology ANT308
Cambium Oncology's ANT308

Cambium Oncology's ANT308

USA Atlanta Immunotherapy Cambium Oncology ANT308
Funding for ANT308!

Funding for ANT308!

USA Immunotherapy Delaware Cambium Oncology ANT308
ANT308: A Cancer Breakthrough

ANT308: A Cancer Breakthrough

USA Atlanta Immunotherapy Cambium Oncology ANT308
BioVaxys Extends Closing

BioVaxys Extends Closing

Canada Vancouver Immunotherapy BioVaxys DPX Technology
Cancer Therapy Breakthroughs

Cancer Therapy Breakthroughs

USA Vancouver Cancer Research Immunotherapy Oncolytics Biotech
Diamyd® Market Potential

Diamyd® Market Potential

Sweden Immunotherapy Stockholm Type 1 Diabetes Diamyd Medical
Diamyd® U.S. Potential

Diamyd® U.S. Potential

Sweden Immunotherapy Stockholm Diamyd Medical Diamyd®
Immunotherapy Acquisition

Immunotherapy Acquisition

United States San Francisco Immunotherapy biotechnology Foundery
TC BioPharm Trading Surge

TC BioPharm Trading Surge

NASDAQ United Kingdom Immunotherapy Edinburgh TC BioPharm
First Patient Dosing of HX044

First Patient Dosing of HX044

Immunotherapy HX044 Hanx Biopharmaceuticals
Cancer Treatment Revolution

Cancer Treatment Revolution

USA Vancouver Immunotherapy Cancer Treatments Oncolytics Biotech
Innovative Cancer Therapies

Innovative Cancer Therapies

USA Vancouver Immunotherapy Cancer Treatments Oncolytics Biotech

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.